Patients & Caregivers
Researching MPS Therapies with Dr. Patricia Dickson of LA BioMed
The Importance of Researcher Involvement in the Rare Disease Community
Discussing Shire's Rare Disease Pipeline with Hartmann Wellhoefer, M.D.
A Sense of Urgency in Sanfilippo Therapy Development
Are Gaucher Disease and Parkinsons Linked?
Cholangiocarcinoma: Care Teams and Patient Support
Cholangiocarcinoma: Early Diagnosis and Unmet Needs
Explaining the Challenges of Pediatric Ulcerative Colitis
Should Adcetris Be Evaluated as a Combination Therapy?
Emmaus Presents Endari Data at ASH
The Evolving Paradigm in Treatment for Hodgkin Lymphoma
Guy Young, MD, on the Recent Revolutions in Hemophilia Treatment
MPN Expert Ruben Mesa on the Anemia-Based Data at ASH
Rigel CEO Encouraged by Company's Progress and Recent FDA Activity
CMO of Catalyst Biosciences Explains the Current State of Hemophilia
Next Page >>
MOST POPULAR ARTICLES
Potential NF1 Therapy Gets Orphan Drug Designation
Clinical Trial for Liver Disease Treatment Imminent After Orphan Drug Designation
New Phase 3 Data Shows Significant Improvements in Behcet's Disease
Microsoft Teams with Shire and EURORDIS to Expedite Rare Disease Diagnosis
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.